Dr. Moghbel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Massachusetts General Hospital
55 Fruit St
Boston, MA 02114Phone+1 617-724-0288Fax+1 408-851-3839
Education & Training
- Stanford University School of MedicineClass of 2017
Certifications & Licensure
- CA State Medical License 2024 - 2026
- NH State Medical License 2024 - 2026
- MA State Medical License 2019 - 2025
- American Board of Nuclear Medicine Nuclear Medicine
Publications & Presentations
PubMed
- 26 citationsImaging Atherosclerosis by PET, With Emphasis on the Role of FDG and NaF as Potential Biomarkers for This Disorder.Michael Mayer, Austin J Borja, Emily C Hancin, Thomas Auslander, Mona-Elisabeth Revheim
Frontiers in Physiology. 2020-10-22 - 93 citations18 F-NaF and 18 F-FDG as molecular probes in the evaluation of atherosclerosisMikaela L. McKenney-Drake, Mateen Moghbel, Koosha Paydary, Mouhamad Alloosh, Sina Houshmand
European Journal of Nuclear Medicine and Molecular Imaging. 2018-07-06 - 23 citationsEffects of age and cardiovascular risk factors on (18)F-FDG PET/CT quantification of atherosclerosis in the aorta and peripheral arteries.Ahmed K Pasha, Mateen Moghbel, Babak Saboury, Mohammed H Gharavi, Björn A. Blomberg
Hellenic Journal of Nuclear Medicine. 2015-01-01
Journal Articles
- 18F-NaF and 18F-FDG as Molecular Probes in the Evaluation of AtherosclerosisMateen C Moghbel, Sharon Moe, Ali Salavati, Abass Alavi, Sina Houshmand, Jeffrey M Sturek, European Journal of Nuclear Medicine and Molecular Imaging
Press Mentions
- Referral Centers Offer High Success, Low Adversity for Complex Inferior Vena Cava Filter RetrievalsOctober 3rd, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: